FDA panel backs Seattle Genetics chemotherapy drug - BusinessWeek

[INCIID News Feed]

ThirdAge
<img alt="" height="1" width="1" />
FDA panel backs Seattle Genetics chemotherapy drug
BusinessWeek
A panel of federal cancer experts has unanimously voted to grant accelerated approval to Seattle Genetics&#39; innovative chemotherapy drug for two types of rare blood cancer. All 10 members of the Food and Drug Administration&#39;s oncology drug panel voted ...
Ahead of the Bell: Seattle Genetics fallsForbes
AM Vitals: FDA Panel Endorses Seattle Genetics Lymphoma DrugWall Street Journal (blog)
FDA Panel Endorses Novel Drug for LymphomaMedPage Today
The Seattle Times -Reuters -Benzinga
all 102 news articles &raquo;


More...